CAS No |
Product Name |
Molecular Formula |
760212-58-6
|
1-(4-Bromophenyl)-2-phenylbenzimidazole;1-(4-Bromophenyl)-2-phenyl-1H-benzimidazole
|
C19H13BrN2
|
760212-73-5
|
5-Bromo-1-methyl-2-phenyl-1H-benzimidazole
|
C14H11BrN2
|
760914-29-2
|
(S)-4-Methyl-2-morpholinemethanamine
|
C6H14N2O
|
760934-24-5
|
2-((1-Methylethyl)amino)-4-thiazolecarboxylic acid
|
C7H10N2O2S
|
760937-92-6
|
Teneligliptin;3-(((2S,4S)-4-(4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl)-2-pyrrolidinyl)carbonyl)thiazolidine
|
C22H30N6OS
|
760941-22-8
|
(R)-3-Amino-3-(thiophen-3-yl)propanoic acid
|
C7H9NO2S
|
760947-12-4
|
6-bromo-4-chloro-2-(2-fluorophenyl)quinazoline
|
C14H7BrClFN2
|
760952-88-3
|
Tris((3-hydroxypropyl-1H-1,2,3-triazol-4-yl)methyl)amine
|
C18H30N10O3
|
760981-83-7
|
Solithromycin;CEM 101; OP 1068
|
C43H65FN6O10
|
760990-08-7
|
3-Fluoro-4-hydroxyphenylboronic acid, pinacol ester
|
C12H16BFO3
|
760995-19-5
|
5-(4-Morpholinyl)-1-indanone
|
C13H15NO2
|
761001-65-4
|
1-(3-BroMo-4-Methylphenyl)piperidine
|
|
761360-22-9
|
Methyl (2S)-4-oxo-2-piperidinecarboxylate
|
C7H11NO3
|
761373-05-1
|
(alphaS,gammaR)-gamma-((3-Carboxy-1-oxopropyl)amino)-alpha-methyl-(1,1'-biphenyl)-4-pentanoic acid 4-ethyl ester
|
C24H29NO5
|
761390-58-3
|
(R)-1-(3-Fluorophenyl)ethylamine
|
C8H10FN
|
761396-82-1
|
(R)-3-Amino-3-(3-cyanophenyl)propanoic acid
|
C10H10N2O2
|
761404-85-7
|
Trityl olmesartan acid;4-(1-Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxylic acid
|
C43H40N6O3
|
761405-37-2
|
Dibenzothiophene-2,8-diboronic acid
|
C12H10B2O4S
|
761423-87-4
|
Ipragliflozin;(1S)-1,5-Anhydro-1-C-(3-((1-benzothiophen-2-yl)methyl)-4-fluorophenyl)-D-glucitol
|
C21H21FO5S
|
761426-65-7
|
2-Cyclopropyl-4-iodo-1H-imidazole;2-Cyclopropyl-5-iodo-1H-imidazole
|
C6H7IN2
|
761435-31-8
|
2-Amino-N-Isopropylbenzenesulfonamide
|
C9H14N2O2S
|
761436-81-1
|
2-((5-Bromo-2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)amino)-N-methylbenzenesulfonamide;ALK inhibitor 1
|
C23H28BrN7O3S
|
761437-28-9
|
NVP-TAE 226;2-((5-Chloro-2-((2-methoxy-4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)amino)-N-methylbenzamide
|
C23H25ClN6O3
|
761438-38-4
|
2-((5-Chloro-2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)amino)-N-methylbenzenesulfonamide;ALK inhibitor 2
|
C23H28ClN7O3S
|
761439-42-3
|
NVP-TAE684;5-Chloro-N2-(2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)-N4-(2-((1-methylethyl)sulfonyl)phenyl)-2,4-pyrimidinediamine
|
C30H40ClN7O3S
|
761440-06-6
|
7-Amino-2-methyl-1-isoindolinone
|
C9H10N2O
|
761440-16-8
|
2,5-Dichloro-N-(2-((1-methylethyl)sulfonyl)phenyl)-4-pyrimidinamine;(2,5-Dichloropyrimidin-4-yl)(2-((propan-2-yl)sulfonyl)phenyl)amine; 2,5-Dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine
|
C13H13Cl2N3O2S
|
761440-65-7
|
1-(1-(3-Methoxy-4-nitrophenyl)-4-piperidinyl)-4-methylpiperazine;1-(1-(3-Methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine
|
C17H26N4O3
|
761440-75-9
|
2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline;(2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amine
|
C17H28N4O
|
761440-87-3
|
1-(4-Amino-3-(methyloxy)phenyl)-4-piperidinol;1-(4-Amino-3-methoxyphenyl)piperidin-4-ol
|
C12H18N2O2
|
761440-91-9
|
2-(Methyloxy)-4-(4-(4-morpholinyl)-1-piperidinyl)aniline
|
C16H25N3O2
|
761441-16-1
|
2-(2-Amino-4-methoxyphenoxy)ethanol
|
C9H13NO3
|
761443-50-9
|
3-((4-(4-Methylpiperazin-1-yl)benzoyl)amino)-1-ethoxycarbonyl-4,6-dihydro-1H-pyrrolo(3,4-c)pyrazole
|
C20H26N6O3
|
761446-44-0
|
1-Methylpyrazole-4-boronic acid pinacol ester;1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
|
C10H17BN2O2
|
761446-45-1
|
1-Benzyl-1H-pyrazole-4-boronic acid pinacol ester;1-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
|
C16H21BN2O2
|
761447-63-6
|
2-(4-Bromo-1,3-thiazol-2-yl)-2-propanol
|
C6H8BrNOS
|
761460-03-1
|
(R)-4-Boc-3-morpholineacetic acid
|
C11H19NO5
|
761460-08-6
|
Paliperidone N-oxide;3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-oxido-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
|
C23H27FN4O4
|
762233-62-5
|
1,4,5,6-Tetrahydro-1-methylpyrrolo(3,4-c)pyrazole
|
C6H9N3
|
762240-09-5
|
4-(1H-Pyrazol-1-yl)piperidine
|
C8H13N3
|
762240-92-6
|
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-(1,2,4)triazolo(4,3-a)pyrazine hydrochloride
|
C6H7F3N4.HCl
|
762240-94-8
|
8-Phenyl-3-(trifluoromethyl)-5,6,7,8-tetrahydro-(1,2,4)triazolo(4,3-a)pyrazine hydrochloride
|
C12H11F3N4.HCl
|
762240-99-3
|
1-(Chloroacetyl)-2-(Trifluoroacetyl)Hydrazine
|
C4H4ClF3N2O2
|
762243-26-5
|
5-(3-Methylphenyl)-1,3-cyclohexanedione
|
C13H14O2
|
762262-07-7
|
4-(Cyclohexylaminocarbonyl)Phenylboronic Acid
|
C13H18BNO3
|
762262-09-9
|
2-Methoxypyridine-4-boronic acid
|
C6H8BNO3
|
762262-11-3
|
3-(2-Cyanoethylaminocarbonyl)Phenylboronic Acid
|
C10H11BN2O3
|
762263-66-1
|
(4-Hydroxy-3-methylphenyl)boronic acid
|
C7H9BO3
|
762263-92-3
|
2-Hydroxymethyl-4-Methoxyphenylboronic Acid
|
C8H11BO4
|
762287-48-9
|
5-[4-(trifluoromethyl)phenyl]pyridine-2-carboxylic acid
|
C13H8F3NO2
|